“…Although they are heterogenous, LAD285, BP180, and BP230 have been identified as major target antigens in LABD. Particularly, BP180, the NC16A domain, or the soluble 120kDA/97kDa ectodomain has been considered to contain the major targets of IgG and IgA antibodies in BP, LABD, and other immunobullous diseases (50). Although there are only a few reports on target antigens in drug‐induced LABD (30–32), the same antigens as idiopathic LABD have been identified (Table 2).…”